We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Test Being Developed for Hitherto Unrecognized Endurance Enhancers

By LabMedica International staff writers
Posted on 15 Jan 2009
A new test will allow sports officials to screen for emerging performance-enhancing drugs.

The test detects a core chemical structure belonging to a class of compounds called benzothiazepines. These compounds stabilize protein channels that would otherwise leak calcium from muscle cells during strenuous exercise. Calcium is needed for muscle contraction and the leaking effect weakens the contractions and causes muscle fatigue.

Dr. Mario Thevis, director of the center for preventive doping research at the German Sport University (Cologne, Germany) and colleagues characterized the compounds according to their weight and molecular structure. This provided a molecular "fingerprint" by which to identify the compounds. Using high-resolution mass spectrometry, JTV-519 and S-107, benzothiazepines currently in development for the treatment of heart abnormalities, were detected in spiked urine at concentrations as low as 0.1 ng/mL.

The Beijing Olympics 2008 (China) were remarkably drug free; only six athletes were caught during the games and three more cases identified after the games closed. It is possible that some athletes were using drugs that could not be detected by available tests. Perhaps they used compounds that had not yet been tested in humans, but were known to have performance-enhancing properties in mice.

"We used the common approaches that are employed for detecting anabolic agents. Our work showed that we could identify the right compounds and that we have a sensitive test," said Dr. Thevis.

Related Links:
German Sport University




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automated Staining Unit
RAL Stainer

Latest Clinical Chem. News

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
15 Jan 2009  |   Clinical Chem.

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
15 Jan 2009  |   Clinical Chem.

Low-Cost Portable Screening Test to Transform Kidney Disease Detection
15 Jan 2009  |   Clinical Chem.